Insights Into the Recognition and Management of SGLT2-Inhibitor-Associated Ketoacidosis: It's Not Just Euglycemic Diabetic Ketoacidosis.

MLA

Dizon, Stephanie, et al. “Insights Into the Recognition and Management of SGLT2-Inhibitor-Associated Ketoacidosis: It’s Not Just Euglycemic Diabetic Ketoacidosis.” Canadian Journal of Diabetes, vol. 41, no. 5, Oct. 2017, pp. 499–503. EBSCOhost, https://doi.org/10.1016/j.jcjd.2017.05.004.

APA

Dizon, S., Keely, E. J., Malcolm, J., & Arnaout, A. (2017). Insights Into the Recognition and Management of SGLT2-Inhibitor-Associated Ketoacidosis: It’s Not Just Euglycemic Diabetic Ketoacidosis. Canadian Journal of Diabetes, 41(5), 499–503. https://doi.org/10.1016/j.jcjd.2017.05.004

Chicago

Dizon, Stephanie, Erin J Keely, Janine Malcolm, and Amel Arnaout. 2017. “Insights Into the Recognition and Management of SGLT2-Inhibitor-Associated Ketoacidosis: It’s Not Just Euglycemic Diabetic Ketoacidosis.” Canadian Journal of Diabetes 41 (5): 499–503. doi:10.1016/j.jcjd.2017.05.004.